Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft vs Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Post-approval studies (Phase 4)Study completedNCT02156570
What this trial is testing

DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral)

Who this might be right for
Hepatitis C
Kirby Institute 20
Testing effectiveness (Phase 2)UnknownNCT03840512
What this trial is testing

An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)

Who this might be right for
Prevention aGVHD
Kalytera Therapeutics Israel, Ltd. 36
Early research (Phase 1)Looking for participantsNCT04678401
What this trial is testing

IS-free Treg HaploHCT

Who this might be right for
Stem Cell Transplant ComplicationsGraft Vs Host DiseaseMyeloid Leukemia, Acute+2 more
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT01665677
What this trial is testing

Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft vs Host Disease
Mehdi Hamadani 69
Early research (Phase 1)Ended earlyNCT04070781
What this trial is testing

Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease

Who this might be right for
Steroid Refractory GVHDGraft Vs Host Disease
Columbia University 1
Testing effectiveness (Phase 2)Study completedNCT00186628
What this trial is testing

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Who this might be right for
Leukemia, Mast-CellMantle-cell Lymphoma
Stanford University 36
Testing effectiveness (Phase 2)Ended earlyNCT02396628
What this trial is testing

Ruxolitinib In GvHD

Who this might be right for
Graft vs Host Disease
Prof. Dr. Nikolas von Bubnoff 22
Large-scale testing (Phase 3)UnknownNCT02270307
What this trial is testing

MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis

Who this might be right for
LeukemiaMultiple Myeloma
National Research Center for Hematology, Russia 40
Large-scale testing (Phase 3)Study completedNCT04960644
What this trial is testing

MTX and Steroid as First-line Therapy for aGVHD

Who this might be right for
Acute GVH Disease
Peking University People's Hospital 157